Zomedica Corp. (AMEX:ZOM) Q4 2022 Earnings Call Transcript

And while a pet parent might schedule well patient visit, because they just went six months ago and the dog looks fine, it’s young, running around, catching a ball. If that pet is injured or if they’re sick, we believe that, that pet parent is going to go to the vet, and that’s where our products come in, either to diagnose what the condition is or to treat the condition. And so while we’ll be always sympathetic or empathetic towards what’s happening in the economy, we believe our products, our growth is largely unaffected by a downturn in the economic situation.

Paul Kuntz: Okay. We have reached the end of the question-and-answer session. I’d now like to turn the call back over to management for closing comments.

Larry Heaton: Okay. So thank you for those of you that have listened in and that follow the company. We appreciate the support of our shareholders, and we appreciate your interest in Zomedica. We especially appreciative of those that ask questions. It gives us an opportunity to more fully explain how we look at things. We welcome any future interactions if you have questions as Paul mentioned earlier, those other questions that have come in on the website, we’ll endeavor to get those answered rather quickly if we haven’t already answered them. And we look forward to being good stewards of your invested capital as we continue to grow Zomedica in the quarters and years to come. Thank you.

Operator: This concludes today’s conference. You may disconnect your lines at this time, and we thank you for your participation.